Dr. Chhanda Charan Danta| Medicinal Chemistry | Best Researcher Award |

Florida International University,United States

Professional Profiles:

👨‍🎓 Bio Summary:

Dr. Chhanda Charan Danta is a self-driven scientist dedicated to advancing cancer, Alzheimer’s, and chronic disease research through cutting-edge medicinal chemistry and pharmacological screening. With a robust academic background, prestigious awards, and impactful research contributions, he is a leader in therapeutic innovation and translational science.

🎓 Educational Background:

Dr. Chhanda Charan Danta earned his Ph.D. in Pharmaceutical Chemistry from Panjab University, India, where his research focused on synthesizing and studying piperazine derivatives as potential cognition enhancers. He completed his Master’s in Pharmaceutical Chemistry at IIT-Banaras Hindu University, with work on designing and synthesizing quinazoline derivatives for anticancer and anticonvulsant activity. His academic journey began with a Bachelor’s degree in Pharmaceutical Sciences from Biju Patnaik University of Technology, where he explored antidepressant-like activity in benzilic acid derivatives.

🔍 Research Focus:

Dr. Danta’s research centers on anticancer and anti-Alzheimer’s drug discovery, diabetic kidney disease (DKD), and the tumor microenvironment. He specializes in synthesizing bioactive small molecules, bifunctional compounds for extracellular protein degradation, and molecular fluorescent probes. His multidisciplinary expertise spans medicinal chemistry, enzymology, and biological screening.

🏆 Honors & Awards:

Dr. Danta has received accolades such as the prestigious ACS Publications Award and recognition in retrosynthesis competitions, reaching the final round of the ISC-RSC Retrosynthesis Challenge 2022. He has been offered significant research positions, including Postdoctoral Associate at Florida International University and Associate Research Scientist at Yale University. Additionally, he was selected for a European Commission Horizon 2020 research project funded by the Innovative Medicines Initiative.

💼 Professional Experience:

Dr. Danta has held esteemed research roles at institutions like Yale University, where he contributed to molecular pharmacology and chemistry projects, including enzyme activation and extracellular protein degradation. Currently a Postdoctoral Associate at Florida International University, he focuses on synthesizing and screening bioactive small molecules. His career reflects advanced skills in molecular modeling, cellular assays, and drug discovery technologies

📚 Top Noted Publications :

The Discovery and Development of New Potential Antioxidant Agents for the Treatment of Neurodegenerative Diseases

Authors: CC Danta, P Piplani

Journal: Expert Opinion on Drug Discovery

Citations: 57

Index: 9(10), 1205-1222

Year: 2014

Antimicrobial Evaluation of Mangiferin and Its Synthesized Analogues

Authors: SK Singh, RM Tiwari, SK Sinha, CC Danta, SK Prasad

Journal: Asian Pacific Journal of Tropical Biomedicine

Citations: 48

Index: 2(2), S884-S887

Year: 2012

Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer’s Dementia Patients with SARS-CoV-2 Infection

Author: CC Danta

Journal: ACS Chemical Neuroscience

Citations: 32

Index: –

Year: 2020

SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options

Author: CC Danta

Journal: ACS Pharmacol. Transl. Sci.

Citations: 28

Index: –

Year: 2021

Design and Synthesis of Newer Potential 4-(N-Acetylamino) Phenol Derived Piperazine Derivatives as Potential Cognition Enhancers

Authors: P Piplani, CC Danta

Journal: Bioorganic Chemistry

Citations: 27

Index: 60, 64-73

Year: 2015

Conclusion:

Dr. Chhanda Charan Danta’s profile highlights his innovative contributions to pharmaceutical chemistry, particularly in anticancer drug discovery and synthetic medicinal chemistry. His experience at prestigious institutions and his array of technical skills make him a compelling candidate for the “Best Researcher Award.”